5Lee CB, Morris DE, Fried DB, et al. Current and evolving treatment options for limited stage small cell lung cancer [ J ]. Curr Opin Oncol, 2006, 18(2) : 162-172.
6Portela-Gomes GM, Grimelius L, Stridsberg M, et al. Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung[ J]. Virchows Arch, 2005, 446(6) : 604-612.
7Bcrglum T, Rehfeld JF, Drivsholm LB, et al. Processing-independent quantitation of chromogranin a in plasma from patients with neuroendocrine tumors and small-cell lung carcinomas [ J ]. Clin Chem, 2007, 53(3): 438-446.
8Moss AC, Jacobson GM, Walker LE, et al. SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer[ J]. Clin Cancer Res, 2009, 15 ( 1 ) : 274-283.
9Taneja TK, Sharma SK. Markers of small cell lung cancer [ J ]. World J Surg Oncol, 2004, 2: 10.
10Abidin AZ, Garassino MC, Califano R, et al. Targeted therapies in small cell lung cancer: a review[ J]. Ther Adv Med Oncol, 2010, 2 ( 1 ) : 25-37.
